Research ArticleArticle
The Development and Evaluation of Personalized Training in Shared Decision-making Skills for Rheumatologists
Sehrash Mahmood, Johanna M.W. Hazes, Petra Veldt, Piet van Riel, Robert Landewé, Hein Bernelot Moens and Annelieke Pasma
The Journal of Rheumatology April 2019, jrheum.180780; DOI: https://doi.org/10.3899/jrheum.180780
Sehrash Mahmood
From the Amsterdam Rheumatology and Immunology Center, Amsterdam; Erasmus Medical Center, Department of Rheumatology, Rotterdam; Reinier de Graaf Gasthuis, Department of Rheumatology, Delft; Radboud University Medical Center, Radboud Institute for Health Sciences, IQ Healthcare, Nijmegen; Ziekenhuis Groep Twente, Department of Rheumatology, Almelo, the Netherlands. Financial support for the study was provided by Pfizer. S. Mahmood, MSc, Amsterdam Rheumatology and Immunology Center; J.M. Hazes, MD, PhD, Erasmus Medical Center, Department of Rheumatology; P. Veldt, MD, PhD, Reinier de Graaf Gasthuis, Department of Rheumatology; P. van Riel, MD, PhD, Radboud University Medical Center, Radboud Institute for Health Sciences, IQ Healthcare; R. Landewé, MD, PhD, Amsterdam Rheumatology and Immunology Center; H. Bernelot Moens, MD, PhD, Ziekenhuis Groep Twente, Department of Rheumatology; A. Pasma, PhD, Erasmus Medical Center, Department of Rheumatology. Address correspondence to Dr. S. Mahmood, Amsterdam Rheumatology and Immunology Center, De Boelelaan 1117, 1081 HV room 3A56, the Netherlands. E-mail: s.mahmood@vumc.nl. Accepted for publication March 7, 2019.
Johanna M.W. Hazes
From the Amsterdam Rheumatology and Immunology Center, Amsterdam; Erasmus Medical Center, Department of Rheumatology, Rotterdam; Reinier de Graaf Gasthuis, Department of Rheumatology, Delft; Radboud University Medical Center, Radboud Institute for Health Sciences, IQ Healthcare, Nijmegen; Ziekenhuis Groep Twente, Department of Rheumatology, Almelo, the Netherlands. Financial support for the study was provided by Pfizer. S. Mahmood, MSc, Amsterdam Rheumatology and Immunology Center; J.M. Hazes, MD, PhD, Erasmus Medical Center, Department of Rheumatology; P. Veldt, MD, PhD, Reinier de Graaf Gasthuis, Department of Rheumatology; P. van Riel, MD, PhD, Radboud University Medical Center, Radboud Institute for Health Sciences, IQ Healthcare; R. Landewé, MD, PhD, Amsterdam Rheumatology and Immunology Center; H. Bernelot Moens, MD, PhD, Ziekenhuis Groep Twente, Department of Rheumatology; A. Pasma, PhD, Erasmus Medical Center, Department of Rheumatology. Address correspondence to Dr. S. Mahmood, Amsterdam Rheumatology and Immunology Center, De Boelelaan 1117, 1081 HV room 3A56, the Netherlands. E-mail: s.mahmood@vumc.nl. Accepted for publication March 7, 2019.
Petra Veldt
From the Amsterdam Rheumatology and Immunology Center, Amsterdam; Erasmus Medical Center, Department of Rheumatology, Rotterdam; Reinier de Graaf Gasthuis, Department of Rheumatology, Delft; Radboud University Medical Center, Radboud Institute for Health Sciences, IQ Healthcare, Nijmegen; Ziekenhuis Groep Twente, Department of Rheumatology, Almelo, the Netherlands. Financial support for the study was provided by Pfizer. S. Mahmood, MSc, Amsterdam Rheumatology and Immunology Center; J.M. Hazes, MD, PhD, Erasmus Medical Center, Department of Rheumatology; P. Veldt, MD, PhD, Reinier de Graaf Gasthuis, Department of Rheumatology; P. van Riel, MD, PhD, Radboud University Medical Center, Radboud Institute for Health Sciences, IQ Healthcare; R. Landewé, MD, PhD, Amsterdam Rheumatology and Immunology Center; H. Bernelot Moens, MD, PhD, Ziekenhuis Groep Twente, Department of Rheumatology; A. Pasma, PhD, Erasmus Medical Center, Department of Rheumatology. Address correspondence to Dr. S. Mahmood, Amsterdam Rheumatology and Immunology Center, De Boelelaan 1117, 1081 HV room 3A56, the Netherlands. E-mail: s.mahmood@vumc.nl. Accepted for publication March 7, 2019.
Piet van Riel
From the Amsterdam Rheumatology and Immunology Center, Amsterdam; Erasmus Medical Center, Department of Rheumatology, Rotterdam; Reinier de Graaf Gasthuis, Department of Rheumatology, Delft; Radboud University Medical Center, Radboud Institute for Health Sciences, IQ Healthcare, Nijmegen; Ziekenhuis Groep Twente, Department of Rheumatology, Almelo, the Netherlands. Financial support for the study was provided by Pfizer. S. Mahmood, MSc, Amsterdam Rheumatology and Immunology Center; J.M. Hazes, MD, PhD, Erasmus Medical Center, Department of Rheumatology; P. Veldt, MD, PhD, Reinier de Graaf Gasthuis, Department of Rheumatology; P. van Riel, MD, PhD, Radboud University Medical Center, Radboud Institute for Health Sciences, IQ Healthcare; R. Landewé, MD, PhD, Amsterdam Rheumatology and Immunology Center; H. Bernelot Moens, MD, PhD, Ziekenhuis Groep Twente, Department of Rheumatology; A. Pasma, PhD, Erasmus Medical Center, Department of Rheumatology. Address correspondence to Dr. S. Mahmood, Amsterdam Rheumatology and Immunology Center, De Boelelaan 1117, 1081 HV room 3A56, the Netherlands. E-mail: s.mahmood@vumc.nl. Accepted for publication March 7, 2019.
Robert Landewé
From the Amsterdam Rheumatology and Immunology Center, Amsterdam; Erasmus Medical Center, Department of Rheumatology, Rotterdam; Reinier de Graaf Gasthuis, Department of Rheumatology, Delft; Radboud University Medical Center, Radboud Institute for Health Sciences, IQ Healthcare, Nijmegen; Ziekenhuis Groep Twente, Department of Rheumatology, Almelo, the Netherlands. Financial support for the study was provided by Pfizer. S. Mahmood, MSc, Amsterdam Rheumatology and Immunology Center; J.M. Hazes, MD, PhD, Erasmus Medical Center, Department of Rheumatology; P. Veldt, MD, PhD, Reinier de Graaf Gasthuis, Department of Rheumatology; P. van Riel, MD, PhD, Radboud University Medical Center, Radboud Institute for Health Sciences, IQ Healthcare; R. Landewé, MD, PhD, Amsterdam Rheumatology and Immunology Center; H. Bernelot Moens, MD, PhD, Ziekenhuis Groep Twente, Department of Rheumatology; A. Pasma, PhD, Erasmus Medical Center, Department of Rheumatology. Address correspondence to Dr. S. Mahmood, Amsterdam Rheumatology and Immunology Center, De Boelelaan 1117, 1081 HV room 3A56, the Netherlands. E-mail: s.mahmood@vumc.nl. Accepted for publication March 7, 2019.
Hein Bernelot Moens
From the Amsterdam Rheumatology and Immunology Center, Amsterdam; Erasmus Medical Center, Department of Rheumatology, Rotterdam; Reinier de Graaf Gasthuis, Department of Rheumatology, Delft; Radboud University Medical Center, Radboud Institute for Health Sciences, IQ Healthcare, Nijmegen; Ziekenhuis Groep Twente, Department of Rheumatology, Almelo, the Netherlands. Financial support for the study was provided by Pfizer. S. Mahmood, MSc, Amsterdam Rheumatology and Immunology Center; J.M. Hazes, MD, PhD, Erasmus Medical Center, Department of Rheumatology; P. Veldt, MD, PhD, Reinier de Graaf Gasthuis, Department of Rheumatology; P. van Riel, MD, PhD, Radboud University Medical Center, Radboud Institute for Health Sciences, IQ Healthcare; R. Landewé, MD, PhD, Amsterdam Rheumatology and Immunology Center; H. Bernelot Moens, MD, PhD, Ziekenhuis Groep Twente, Department of Rheumatology; A. Pasma, PhD, Erasmus Medical Center, Department of Rheumatology. Address correspondence to Dr. S. Mahmood, Amsterdam Rheumatology and Immunology Center, De Boelelaan 1117, 1081 HV room 3A56, the Netherlands. E-mail: s.mahmood@vumc.nl. Accepted for publication March 7, 2019.
Annelieke Pasma
From the Amsterdam Rheumatology and Immunology Center, Amsterdam; Erasmus Medical Center, Department of Rheumatology, Rotterdam; Reinier de Graaf Gasthuis, Department of Rheumatology, Delft; Radboud University Medical Center, Radboud Institute for Health Sciences, IQ Healthcare, Nijmegen; Ziekenhuis Groep Twente, Department of Rheumatology, Almelo, the Netherlands. Financial support for the study was provided by Pfizer. S. Mahmood, MSc, Amsterdam Rheumatology and Immunology Center; J.M. Hazes, MD, PhD, Erasmus Medical Center, Department of Rheumatology; P. Veldt, MD, PhD, Reinier de Graaf Gasthuis, Department of Rheumatology; P. van Riel, MD, PhD, Radboud University Medical Center, Radboud Institute for Health Sciences, IQ Healthcare; R. Landewé, MD, PhD, Amsterdam Rheumatology and Immunology Center; H. Bernelot Moens, MD, PhD, Ziekenhuis Groep Twente, Department of Rheumatology; A. Pasma, PhD, Erasmus Medical Center, Department of Rheumatology. Address correspondence to Dr. S. Mahmood, Amsterdam Rheumatology and Immunology Center, De Boelelaan 1117, 1081 HV room 3A56, the Netherlands. E-mail: s.mahmood@vumc.nl. Accepted for publication March 7, 2019.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
The Development and Evaluation of Personalized Training in Shared Decision-making Skills for Rheumatologists
Sehrash Mahmood, Johanna M.W. Hazes, Petra Veldt, Piet van Riel, Robert Landewé, Hein Bernelot Moens, Annelieke Pasma
The Journal of Rheumatology Apr 2019, jrheum.180780; DOI: 10.3899/jrheum.180780
The Development and Evaluation of Personalized Training in Shared Decision-making Skills for Rheumatologists
Sehrash Mahmood, Johanna M.W. Hazes, Petra Veldt, Piet van Riel, Robert Landewé, Hein Bernelot Moens, Annelieke Pasma
The Journal of Rheumatology Apr 2019, jrheum.180780; DOI: 10.3899/jrheum.180780